80 related articles for article (PubMed ID: 9099163)
1. Managing benign prostatic hyperplasia.
Barkin J
CMAJ; 1997 Apr; 156(7):978-9. PubMed ID: 9099163
[No Abstract] [Full Text] [Related]
2. Drug treatment for benign prostatic hyperplasia. Several trials have shown benefit of finasteride.
Collins GN
BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270474
[No Abstract] [Full Text] [Related]
3. Finasteride for BPH.
Johnson KH; Casey CM
J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104
[No Abstract] [Full Text] [Related]
4. FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.
Rich KT; Safranek S
Am Fam Physician; 2008 Mar; 77(5):665-6. PubMed ID: 18350766
[No Abstract] [Full Text] [Related]
5. Saw palmetto extracts for benign prostatic hyperplasia.
Segars LW
J Fam Pract; 1999 Feb; 48(2):88-9. PubMed ID: 10037530
[No Abstract] [Full Text] [Related]
6. Benign prostatic hypertrophy: update on drug therapy.
Tejani A; Musini V; Perry TL; Mintzes B; Wright JM
Can Fam Physician; 2006 Sep; 52(9):1075-6, 1077-8. PubMed ID: 17279217
[No Abstract] [Full Text] [Related]
7. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
[No Abstract] [Full Text] [Related]
8. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
[TBL] [Abstract][Full Text] [Related]
9. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].
Mazo EB
Urologiia; 2001; (3):20-2. PubMed ID: 11505535
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
Hausmann R; Thalmann G; Reich O; Steif CG
Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
[No Abstract] [Full Text] [Related]
11. Benign prostatic hyperplasia.
Doherty AP
Hosp Med; 2003 Feb; 64(2):114. PubMed ID: 12619342
[No Abstract] [Full Text] [Related]
12. Questions whether clients were properly informed about treatment protocol.
Koltveit AJ
J Am Vet Med Assoc; 2001 Jun; 218(11):1721-2. PubMed ID: 11394816
[No Abstract] [Full Text] [Related]
13. Drug treatment for benign prostatic hyperplasia. To interpret PSA concentrations in patients taking finasteride, multiply them by two.
Taneja S
BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270475
[No Abstract] [Full Text] [Related]
14. [Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia].
de la Taille A
Prog Urol; 2008 Apr; 18 Suppl 3():S53-7. PubMed ID: 18455085
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
[TBL] [Abstract][Full Text] [Related]
16. Finasteride in benign prostatic hyperplasia.
Verhamme KM; Bosch RJ; Sturkenboom MC
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
[No Abstract] [Full Text] [Related]
17. Second opinion. I have benign prostatic hyperplasia. The drug my doctor prescribed has helped somewhat, but I'm still making a lot of trips to the bathroom at night. Short of surgery, are there any new approaches to managing this condition that might be more helpful?
Mayo Clin Health Lett; 2002 Dec; 20(12):8. PubMed ID: 12526112
[No Abstract] [Full Text] [Related]
18. Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
Prescrire Int; 2007 Aug; 16(90):147. PubMed ID: 17724838
[TBL] [Abstract][Full Text] [Related]
19. [Benign prostatic hyperplasia: medical therapy].
Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
Denti L; Pasolini G; Cortellini P; Sanfelici L; Benedetti R; Cecchetti A; Ferretti S; Banchini A; Ablondi F; Valenti G
J Endocrinol Invest; 1999; 22(10 Suppl):70-1. PubMed ID: 10727053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
